Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)
- Citation:
- Ann Surg vol 261 (3) 547-552
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 4
- Parents:
- 993
- Children:
- None
- Pharmas:
- Grants:
- U10 CA180790, U10CA180821, U10CA180882, CA33601, U10 CA76001, P30 CA016672, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180790, P30 CA015083, U10 CA076001, U10 CA180799, U10 CA180870, CA31946
- Corr. Author:
- Authors:
- Judy C. Boughey Vera J. Suman Elizabeth A. Mittendorf Gretchen M. Ahrendt Lee G. Wilke Bret Taback A. Marilyn Leitch Teresa S. Flippo-Morton Henry M. Kuerer Monet Bowling Kelly K. Hunt
- Networks:
- COLUMBIA, LAPS-CO070, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-TX011, LAPS-TX035, LAPS-WI020
- Study
- ACOSOG-Z1071
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- sentinel node, neoadjuvant chemotherapy, breast cancer, identification rate